Retraction
Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway
Paper Information
Record ID:
52488
Journal:
Publication Date:
January 04, 2022
Retraction Date:
February 20, 2024
(1.7 year years ago)
Subjects:
Institution:
Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University, Jiangxi, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1080/21655979.2024.2299577Additional Notes:
See also: https://pubpeer.com/publications/59D3C959923B8B5462EF9B59AE7C2D
Citations (10)
10
Total Citations4
Post-Retraction(40.0%)
5
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
3
Within 1 year
0
After 2+ years
467
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Diagnostic and Prognostic Potential of Circulating miR-1301-3p, miR-106a-5p, miR-129-5p, miR-3613-3p, and miR-647 microRNAs in Gastric Cancer
Irina V. Bure, Ekaterina A. Vetchinkina, Alexey I. Kalinkin et al. (8 authors)
Biochemistry (Moscow)
Published: Jun 2025
467 days after retraction
METTL3: a multifunctional regulator in diseases
Na Li, Wei Xiang, J.J. Dai et al. (5 authors)
Molecular and Cellular Biochemistry
Published: Jan 2025
5 citations
5 citations
339 days after retraction
RNA modifications in the progression of liver diseases: from fatty liver to cancer
Simiao Li‐Sauerwine, Wajahat Z. Mehal, Xinshou Ouyang
Science China Life Sciences
Open Access
Published: May 2024
6 citations
6 citations
97 days after retraction
Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors
Mehrdad Hashemi, Padideh Daneii, Mahya Asadalizadeh et al. (16 authors)
The International Journal of Biochemistry & Cell Biology
Published: Mar 2024
1 citation
1 citation
29 days after retraction
Diagnostic and therapeutic potentials of methyltransferase-like 3 in liver diseases
Xiaojuan Su, Ruifeng Lu, Yi Qu et al. (4 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Feb 2024
6 citations
6 citations
19 days before retraction
Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications
Qingmiao Shi, Qingfei Chu, Yifan Zeng et al. (8 authors)
Cell Communication and Signaling
Open Access
Published: Dec 2023
10 citations
10 citations
64 days before retraction
New insights into the regulation of METTL3 and its role in tumors
Jin Qiu, Huinan Qu, Chengshi Quan
Cell Communication and Signaling
Open Access
Published: Nov 2023
24 citations
24 citations
89 days before retraction
The bidirectional interplay between ncRNAs and methylation modifications in gastrointestinal tumors
Minyu Kong, Yu Xiao, Wenzhi Guo et al. (4 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2023
5 citations
5 citations
415 days before retraction
Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-κB) pathway
Yun Zhou, Weiwei Tang, Han Zhuo et al. (7 authors)
Bioengineered
Open Access
Published: Feb 2022
68 citations
68 citations
741 days before retraction
Quick Stats
Total Citations:
19
Years Since Retraction:
1.7 year
Open Access:
Yes
Last Checked:
Jul 24, 2025